» Articles » PMID: 9153254

Site-directed Mutagenesis of Human Leukotriene C4 Synthase

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1997 May 23
PMID 9153254
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The functional characteristics of leukotriene C4 synthase (LTC4S), which specifically conjugates leukotriene A4 with GSH, were assessed by mutagenic analysis. Human LTC4S and the 5-lipoxygenase-activating protein share substantial amino acid identity and predicted secondary structure. The mutation of Arg-51 of LTC4S to Thr or Ile abolishes the enzyme function, whereas the mutation of Arg-51 to His or Lys provides a fully active recombinant protein. The mutations Y59F, Y97F, Y93F, N55A, V49F, and A52S increase the Km of the recombinant microsomal enzyme for GSH. The mutation Y93F also markedly reduces enzyme function and increases the optimum for pH-dependent activity. The deletion of the third hydrophobic domain with the carboxyl terminus abolishes the enzyme activity, and function is restored by the substitution of the third hydrophobic domain and carboxyl terminus of 5-lipoxygenase-activating protein for that of LTC4S. Mutations of C56S and C82V alone or together and the deletion of Lys-2 and Asp-3 of LTC4S do not alter enzyme function. The direct linkage of two LTC4S monomers by a 12-amino acid bridge provides an active dimer, and the same bridging of inactive R51I with a wild-type monomer creates an active pseudo-dimer with function similar to that of the wild-type enzyme. These results suggest that in the catalytic function of LTC4S, Arg-51 probably opens the epoxide ring and Tyr-93 provides the thiolate anion of GSH. Furthermore, the monomer has independent conjugation activity, and dimerization of LTC4S maintains the proper protein structure.

Citing Articles

The enzymology of human eicosanoid pathways: the lipoxygenase branches.

Biringer R Mol Biol Rep. 2020; 47(9):7189-7207.

PMID: 32748021 DOI: 10.1007/s11033-020-05698-8.


Supergenomic network compression and the discovery of EXP1 as a glutathione transferase inhibited by artesunate.

Lisewski A, Quiros J, Ng C, Adikesavan A, Miura K, Putluri N Cell. 2014; 158(4):916-928.

PMID: 25126794 PMC: 4167585. DOI: 10.1016/j.cell.2014.07.011.


The catalytic architecture of leukotriene C4 synthase with two arginine residues.

Saino H, Ukita Y, Ago H, Irikura D, Nisawa A, Ueno G J Biol Chem. 2011; 286(18):16392-401.

PMID: 21454538 PMC: 3091245. DOI: 10.1074/jbc.M110.150177.


Arginine 104 is a key catalytic residue in leukotriene C4 synthase.

Rinaldo-Matthis A, Wetterholm A, Molina D, Holm J, Niegowski D, Ohlson E J Biol Chem. 2010; 285(52):40771-6.

PMID: 20980252 PMC: 3003377. DOI: 10.1074/jbc.M110.105940.


Enhanced expressions and activations of leukotriene C4 synthesis enzymes in D-galactosamine/lipopolysaccharide-induced rat fulminant hepatic failure model.

Ma K, Yang H, Chen Z, Qi L, Zhu D, Lou Y World J Gastroenterol. 2008; 14(17):2748-56.

PMID: 18461660 PMC: 2709038. DOI: 10.3748/wjg.14.2748.